What have we learned from murine models of otitis media?

What have we learned from murine models of otitis media?

Otitis media (OM) is a common cause of childhood hearing loss. The large medical costs involved in treating this condition have meant that research to understand the pathology of this disease and identify new therapeutic interventions is important. There is evidence that susceptibility to OM has a s...

Bibliografski detalji
Glavni autori:	Tyrer, H, Crompton, M, Bhutta, M
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

edison - a novel model of otitis media
od: Crompton, M
Izdano: (2014)

Mouse models of otitis media: strengths and limitations.
od: Bhutta, M
Izdano: (2012)

What Have We Learned (or Expect to) From Analysis of Murine Genetic Models Related to Substance Use Disorders?
od: Gary Peltz, i dr.
Izdano: (2022-01-01)

Genetics of chronic otitis media: a mouse to man approach
od: Bhutta, M
Izdano: (2012)

Decreased Expression of Aquaporins in Otitis Media: What About Chronic Otitis Media?
od: Shin Hye Kim, i dr.
Izdano: (2019-08-01)

Chronic otitis media in mucopolysaccharidosis may not be due to Eustachian tube dysfunction.
od: Bhutta, M
Izdano: (2011)

What have we learned?
od: Peter Rodgers, i dr.
Izdano: (2021-12-01)

What have we learned from the pandemic?
od: Iêda Maria Barbosa Aleluia
Izdano: (2021-03-01)

What have we learned from brucellosis in the mouse model?
od: Grilló María-Jesús, i dr.
Izdano: (2012-04-01)

The pilocarpine model of epilepsy: what have we learned?
od: Fulvio A. Scorza, i dr.
Izdano: (2009-09-01)

HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.
od: Cheeseman, M, i dr.
Izdano: (2011)

Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
od: Đurović Branka, i dr.
Izdano: (2016-01-01)

GOAL: What Have We Learned?
od: Leek Timothy
Izdano: (2005-09-01)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
od: Jose Gilberto H. Vieira
Izdano: (2012-01-01)

A modeling dialog with AI – what do we learn about what we have to learn?
od: Joolingen, Wouter van
Izdano: (2024)

Topical antibiotics for chronic suppurative otitis media
od: Brennan-Jones, C, i dr.
Izdano: (2018)

What have we learned? : ten years on /
od: Ashkanasy, Neal M., 1945-, i dr.
Izdano: (2011)

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.
od: Michael Crompton, i dr.
Izdano: (2017-08-01)

Unraveling the genetics of otitis media: from mouse to human and back again.
od: Rye, MS, i dr.
Izdano: (2011)

What we have learned from the Myriad trials.
od: Hendrix, S, i dr.
Izdano: (2009)

What Have We Not Learned from the Convergence Debate?
od: Leone Leonida
Izdano: (2023-04-01)

What we have learned from the Rigopiano tragedy
od: Antonella Pescini, i dr.
Izdano: (2019-12-01)

Cardiovascular Imaging: What Have We Learned From Animal Models?
od: Arnoldo eSantos, i dr.
Izdano: (2015-10-01)

Hyperoxia and Lungs: What We Have Learned From Animal Models
od: Luciano Amarelle, i dr.
Izdano: (2021-03-01)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
od: María P. Di Yorio, i dr.
Izdano: (2019-02-01)

Topical antibiotics with steroids for chronic suppurative otitis media
od: Brennan-Jones, C, i dr.
Izdano: (2018)

Topical antibiotics for chronic suppurative otitis media
od: Brennan-Jones, CG, i dr.
Izdano: (2019)

Orthopaedic infections: what have we learned?
od: Christopher Lee, MD, i dr.
Izdano: (2023-05-01)

Development Economics: What Have We Learned?
od: Jagdish N. Bhagwati
Izdano: (1984-01-01)

Phage Therapy: What Have We Learned?
od: Andrzej Górski, i dr.
Izdano: (2018-05-01)

COVID-19: what have we learned?
od: Yeh-Li Ho, i dr.
Izdano: (2020-06-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
od: N I Volkova, i dr.
Izdano: (2017-02-01)

The COVID-19 challenge. What have we learned?
od: Adrian Ceccato, i dr.
Izdano: (2022-11-01)

COVID-19 pandemic. What have we learned?
od: Cristina Calvo, i dr.
Izdano: (2021-11-01)

Nonpolyp‐associated otitis media in cats: The little we know
od: Mariana Bezerra Mascarenhas
Izdano: (2022-09-01)

What have we learned from the Young Lives study in Peru?
od: Cueto, S, i dr.
Izdano: (2018)

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways
od: Crompton, M, i dr.
Izdano: (2017)

What we have learned from COVID-19 pandemic?
od: Hsiu-Hsi Chen, i dr.
Izdano: (2021-06-01)

Topical antiseptics for chronic suppurative otitis media
od: Head, K, i dr.
Izdano: (2020)

Otitis media: recent advances in otitis media vaccine development and model systems
od: Ayesha Zahid, i dr.
Izdano: (2024-01-01)